摘要 |
<p>Disclosed is a method of inhibiting fibrosis in a human or animal subject afflicted with a fibrosing disorder. The method comprises administering to the subject an effective fibrosis-inhibiting amount of a compound of formula (I), wherein: n is 1 or 2, R is selected from the group consisting of hydrogen, C1-C4 alkyl, hydroxy, amino, and nitro; and R' is selected from the group consisting of hydrogen and C1-C4 alkyl, or a pharmaceutically acceptable salt thereof. Preferred as a compound of formula (I) is benzoic hydrazide. Pharmaceutical formulations and the use of compounds of formula (I) for making the same are also disclosed.</p> |